Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.

Meletios A DimopoulosA Keith StewartTamás MassziIvan ŠpičkaAlbert OriolRoman HájekLaura RosiñolDavid SiegelGeorgi G MihaylovVesselina Goranova-MarinovaRajnics PeterAleksandr SuvorovRuben NiesvizkyAndrzej JakubowiakJesus San-MiguelHeinz LudwigAntonio PalumboMihaela ObrejaSanjay AggarwalPhilippe Moreau

Published in: British journal of haematology (2017)

clinicaltrials.gov identifier: NCT01080391.

Keyphrases

multiple myeloma
low dose
high dose
acute myeloid leukemia
hodgkin lymphoma
data analysis